tiprankstipranks
Neurocrine (NBIX)
NASDAQ:NBIX
US Market
NBIX
Neurocrine
RESEARCH TOOLSreports

Neurocrine (NBIX) Stock News & Sentiment

1,559 Followers
3 Best Trending Stocks, According to Analysts – 4/7/2026
Premium
Market News
3 Best Trending Stocks, According to Analysts – 4/7/2026
1d ago
AMGN
NBIX
Balanced Risk-Reward After Soleno Acquisition Supports Neutral Stance on Neurocrine
Premium
Ratings
Balanced Risk-Reward After Soleno Acquisition Supports Neutral Stance on Neurocrine
1d ago
NBIX
Neurocrine Biosciences: Vykat XR Acquisition Unlocks Diversified Growth and Upside Potential Despite Near-Term Pipeline Lull
Premium
Ratings
Neurocrine Biosciences: Vykat XR Acquisition Unlocks Diversified Growth and Upside Potential Despite Near-Term Pipeline Lull
1d ago
NBIX
Neurocrine’s Soleno Acquisition: Accretive Rare-Disease Expansion Supporting Long-Term Growth and Buy Rating
Premium
Ratings
Neurocrine’s Soleno Acquisition: Accretive Rare-Disease Expansion Supporting Long-Term Growth and Buy Rating
2d ago
NBIX
Balanced View on Neurocrine Biosciences: Favorable Soleno Acquisition Prospects Offset by Long-Term Ingrezza and Orphan Market Execution Risks
Premium
Ratings
Balanced View on Neurocrine Biosciences: Favorable Soleno Acquisition Prospects Offset by Long-Term Ingrezza and Orphan Market Execution Risks
2d ago
NBIX
Neurocrine to Acquire Soleno, Expanding Rare Disease Portfolio
Premium
Company Announcements
Neurocrine to Acquire Soleno, Expanding Rare Disease Portfolio
2d ago
8K
NBIX
M&A News: Soleno Therapeutics Stock (SLNO) Surges 28% as Neurocrine Biosciences Lines up $2.5B Deal
Premium
Market News
M&A News: Soleno Therapeutics Stock (SLNO) Surges 28% as Neurocrine Biosciences Lines up $2.5B Deal
2d ago
NBIX
SLNO
More NBIX News >

NBIX News on the Web

Neurocrine price target lowered to $176 from $177 at RBC Capital
TipRanks News
Neutral
3 Best Trending Stocks, According to Analysts – 4/7/2026
TipRanks News
Bullish
Arm downgraded, Arista Networks upgraded: Wall Street’s top analyst calls
TipRanks News
Neutral
Company News for Apr 7, 2026
Zacks
Neutral
Jefferies Reaffirms Their Buy Rating on Neurocrine (NBIX)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Theravance Biopharma (TBPH)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Centene (CNC)
TipRanks News
Bullish
Neurocrine price target raised to $166 from $151 at Wedbush
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
NBIX
Sector Average
Media Buzz
This Week35 articles
Weekly Average9.5 articles
News Sentiment
This Week95%
Sector Average66%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NBIX’s Media Buzz Sentiment?
35 articles about NBIX were published this week. In an average week, 9.5 articles are published.
    What is NBIX’s weekly average amount of articles?
    In an average week, 9.5 articles about NBIX are published.
      What is NBIX’s News Sentiment?
      95% of articles about NBIX were positive this week, compared to its sector average of 66%.
        Healthcare Stocks that are Trending in the News
        VCELVericel
        NBIXNeurocrine
        ANGOAngioDynamics
        ORGOOrganogenesis Holdings
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week